Literature DB >> 30930086

Comment on "Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics".

Andrew Greenspan1, Sharon Popik2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30930086      PMCID： PMC6699145          DOI： 10.1016/j.jaad.2019.03.068

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  5 in total

Review 1.  Utility of radiotherapy for treatment of basal cell carcinoma: a review.

Authors:  M Cho; L Gordon; A Rembielak; T C S Woo
Journal:  Br J Dermatol       Date:  2014-10-26       Impact factor: 9.302

2.  Update of the European guidelines for basal cell carcinoma management.

Authors:  Myrto Trakatelli; Colin Morton; Eduardo Nagore; Claas Ulrich; Veronique Del Marmol; Ketty Peris; Nicole Basset-Seguin
Journal:  Eur J Dermatol       Date:  2014 May-Jun       Impact factor: 3.328

3.  Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.

Authors:  Maud H E Jansen; Klara Mosterd; Aimee H M M Arits; Marieke H Roozeboom; Anja Sommer; Brigitte A B Essers; Han P A van Pelt; Patricia J F Quaedvlieg; Peter M Steijlen; Patty J Nelemans; Nicole W J Kelleners-Smeets
Journal:  J Invest Dermatol       Date:  2017-10-16       Impact factor: 8.551

4.  Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial.

Authors:  Hywel C Williams; Fiona Bath-Hextall; Mara Ozolins; Sarah J Armstrong; Graham B Colver; William Perkins; Paul S J Miller
Journal:  J Invest Dermatol       Date:  2016-12-05       Impact factor: 8.551

5.  Guidelines of care for the management of basal cell carcinoma.

Authors:  John Y S Kim; Jeffrey H Kozlow; Bharat Mittal; Jeffrey Moyer; Thomas Olencki; Phillip Rodgers
Journal:  J Am Acad Dermatol       Date:  2018-01-10       Impact factor: 11.527
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.